0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Treating Refractory Hypertension

JAMA. 1966;197(2):42. doi:10.1001/jama.1966.03110020028016.
Text Size: A A A
Published online

ABSTRACT

Therapy-resistant hypertensive patients have been treated successfully with an experimental agent, Georgetown University clinicians report.

Effects of a 20-day regimen of diazoxide have elicited responsiveness to standard agents for as long as two years.

A clinical trial with 16 hypertensive patients was reported to the American Therapeutic Society by Frank A. Finnerty, Jr., MD.

All cases previously were amenable to therapy. Drug resistance, failure to take medications correctly or aggravated vascular disease caused accelerated hypertension.

Doses of methyldopa, guanethidine and hydralazine were increased to near toxic levels. In spite of this there was mean 33% arterial pressure increase.

"Flame shaped" hemorrhages and increased cardiac size also were detected in 11 of the 16 patients. Congestive heart failure developed in seven.

After hospital confinement to assure that out-patient factors were not critical, diazoxide was begun.

For 20 days, intravenous doses of 300 mg were given as often as necessary to maintain

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();